Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Atossa Therapeutics Inc.

    NASDAQ: ATOS · Real-Time Price · USD
    0.90
    0.04 (4.68%)
    At close: Jun 06, 2025, 3:59 PM
    0.92
    1.74%
    After-hours: Jun 06, 2025, 07:43 PM EDT

    Atossa Therapeutics Statistics

    Share Statistics

    Atossa Therapeutics has 129.17M shares outstanding. The number of shares has increased by 2.71% in one year.

    Shares Outstanding

    n/a
    		 129.17M

    Shares Change (YoY)

    n/a
    		 2.71%

    Shares Change (QoQ)

    n/a
    		 2.68%

    Owned by Institutions (%)

    n/a
    		 23.8%

    Shares Floating

    n/a
    		 129.12M

    Failed to Deliver (FTD) Shares

    n/a
    		 10,557

    FTD / Avg. Volume

    n/a
    		 1.55%

    Short Selling Information

    The latest short interest is 7.14M, so 5.53% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.14M

    Short % of Shares Out

    n/a
    		 5.53%

    Short % of Float

    n/a
    		 5.53%

    Short Ratio (days to cover)

    n/a
    		 8.99

    Valuation Ratios

    The PE ratio is -4.66 and the forward PE ratio is -3.18. Atossa Therapeutics's PEG ratio is 0.28.

    PE Ratio

    n/a
    		 -4.66

    Forward PE

    n/a
    		 -3.18

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 1.66

    P/FCF Ratio

    n/a
    		 -5.65

    PEG Ratio

    n/a
    		 0.28
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Atossa Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 14.99, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 14.99

    Quick Ratio

    n/a
    		 14.99

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,700,266.67

    Employee Count

    n/a
    		 15

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -28% in the last 52 weeks. The beta is 0.9, so Atossa Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.9

    52-Week Price Change

    n/a
    		 -28%

    50-Day Moving Average

    n/a
    		 0.78

    200-Day Moving Average

    n/a
    		 1.05

    Relative Strength Index (RSI)

    n/a
    		 57.07

    Average Volume (20 Days)

    n/a
    		 679,898

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -17K

    Operating Income

    n/a
    		 -27.62M

    Net Income

    n/a
    		 -25.5M

    EBITDA

    n/a
    		 -25.49M

    EBIT

    n/a
    		 -25.5M

    Earnings Per Share (EPS)

    n/a
    		 -0.2
    Full Income Statement

    Balance Sheet

    The company has 71.08M in cash and 0 in debt, giving a net cash position of 71.08M.

    Cash & Cash Equivalents

    n/a
    		 71.08M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -211.79M

    Total Assets

    n/a
    		 70.75M

    Working Capital

    n/a
    		 63.32M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -21.03M and capital expenditures -19K, giving a free cash flow of -21.05M.

    Operating Cash Flow

    n/a
    		 -21.03M

    Capital Expenditures

    n/a
    		 -19K

    Free Cash Flow

    n/a
    		 -21.05M

    FCF Per Share

    n/a
    		 -0.17
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ATOS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ATOS is $7, which is 677.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 677.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 20, 2018. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Apr 20, 2018

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 7.4

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist